MAIA Biotechnology, Inc. (MAIA)

MAIA Biotechnology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	10.14	9.6	7.15	10.95	10.57	0.66
Cash & Short-Term Investments	10.14	9.6	7.15	10.95	10.57	0.66
Cash Growth	-12.39%	34.27%	-34.70%	3.56%	1493.82%	-61.19%
Other Receivables	0.08	0.08	0.14	0.3	0.04	-
Receivables	0.08	0.08	0.14	0.3	0.04	-
Prepaid Expenses	0.82	0.47	0.27	0.55	0.05	0.08
Total Current Assets	11.04	10.15	7.56	11.81	10.67	0.75
Long-Term Deferred Charges	-	-	-	0.21	0.65	-
Other Long-Term Assets	0	0	0	0	0	-
Total Assets	11.05	10.16	7.57	12.02	11.33	0.75
Accounts Payable	1.72	1.51	1.64	1.17	0.96	0.15
Accrued Expenses	3.32	2.32	3.3	2.1	1.19	1.51
Short-Term Debt	-	-	-	-	-	0.02
Current Portion of Long-Term Debt	-	-	-	-	-	0.01
Total Current Liabilities	5.04	3.83	4.94	3.27	2.15	1.69
Long-Term Debt	-	-	-	-	-	0.43
Other Long-Term Liabilities	2.13	2.69	2.15	0.25	-	0.24
Total Liabilities	7.17	6.52	7.09	3.51	2.15	2.36
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	101	90.9	64.47	52.73	37.62	12.6
Retained Earnings	-97.1	-87.23	-63.98	-44.21	-28.44	-15.93
Comprehensive Income & Other	-0.03	-0.03	-0.02	-0.02	-	-0
Total Common Equity	3.88	3.63	0.48	8.51	9.18	-3.34
Minority Interest	-	-	-	-	-	1.72
Shareholders' Equity	3.88	3.63	0.48	8.51	9.18	-1.62
Total Liabilities & Equity	11.05	10.16	7.57	12.02	11.33	0.75
Total Debt	-	-	-	-	-	0.46
Net Cash (Debt)	10.14	9.6	7.15	10.95	10.57	0.2
Net Cash Growth	-12.39%	34.27%	-34.70%	3.56%	5195.01%	-88.08%
Net Cash Per Share	0.38	0.43	0.54	1.18	2.00	0.05
Filing Date Shares Outstanding	32.99	29.59	20	11	7.94	4.43
Total Common Shares Outstanding	31.82	26.16	16.99	10.96	7.58	4.43
Working Capital	6	6.32	2.63	8.54	8.53	-0.95
Book Value Per Share	0.12	0.14	0.03	0.78	1.21	-0.75
Tangible Book Value	3.88	3.63	0.48	8.51	9.18	-3.34
Tangible Book Value Per Share	0.12	0.14	0.03	0.78	1.21	-0.75

Updated Mar 21, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q